PMID- 24552858
OWN - NLM
STAT- MEDLINE
DCOM- 20141118
LR  - 20220318
IS  - 1665-2681 (Print)
IS  - 1665-2681 (Linking)
VI  - 13
IP  - 2
DP  - 2014 Mar-Apr
TI  - The prevalence of nonalcoholic fatty liver disease in the Americas.
PG  - 166-78
AB  - Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. 
      The disease is one of the main causes of chronic liver disease worldwide and is 
      directly linked to the increased prevalence of obesity and type 2 diabetes 
      mellitus (T2DM) in the general population. The worldwide prevalence of NAFLD has 
      been estimated at 20-30%, but the prevalence is unknown in the Americas because 
      of a lack of epidemiological studies. However, given the trends in the prevalence 
      of diabetes and obesity, the prevalence of NAFLD and its consequences are 
      expected to increase in the near future. The aim of the present study is to 
      present the current data on the prevalence of NAFLD in the Americas. We performed 
      an electronic search of the main databases from January 2000 to September 2013 
      and identified 356 reports that were reviewed. We focused on the epidemiology and 
      prevalence of known NAFLD risk factors including obesity, T2DM, and the metabolic 
      syndrome (MS). The prevalence of the MS was highest in the United States, Mexico, 
      Costa Rica, Puerto Rico, Chile, and Venezuela. In addition, Puerto Rico, Guyana, 
      and Mexico have the highest prevalence of T2DM in the Americas, while USA has the 
      most people with T2DM. In conclusion, the prevalence rates of NAFLD and obesity 
      were highest in the United States, Belize, Barbados, and Mexico.
FAU - Lopez-Velazquez, Jorge A
AU  - Lopez-Velazquez JA
AD  - Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
FAU - Silva-Vidal, Karen V
AU  - Silva-Vidal KV
AD  - Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
FAU - Ponciano-Rodriguez, Guadalupe
AU  - Ponciano-Rodriguez G
AD  - Departamento de Salud Publica, Facultad de Medicina, UNAM. Mexico City, Mexico.
FAU - Chavez-Tapia, Norberto C
AU  - Chavez-Tapia NC
AD  - Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
FAU - Arrese, Marco
AU  - Arrese M
AD  - Departamento de Gastroenterologia, Pontificia Universidad Catolica de Chile, 
      Santiago, Chile.
FAU - Uribe, Misael
AU  - Uribe M
AD  - Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
FAU - Mendez-Sanchez, Nahum
AU  - Mendez-Sanchez N
AD  - Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Mexico
TA  - Ann Hepatol
JT  - Annals of hepatology
JID - 101155885
SB  - IM
MH  - Central America/epidemiology
MH  - Diabetes Complications/complications/epidemiology
MH  - Fatty Liver/*epidemiology/etiology
MH  - Humans
MH  - Non-alcoholic Fatty Liver Disease
MH  - North America/epidemiology
MH  - Obesity/complications/epidemiology
MH  - Prevalence
MH  - South America/epidemiology
EDAT- 2014/02/21 06:00
MHDA- 2014/11/19 06:00
CRDT- 2014/02/21 06:00
PHST- 2014/02/21 06:00 [entrez]
PHST- 2014/02/21 06:00 [pubmed]
PHST- 2014/11/19 06:00 [medline]
AID - S1665-2681(19)30879-8 [pii]
PST - ppublish
SO  - Ann Hepatol. 2014 Mar-Apr;13(2):166-78.